REGENXBIO, Inc. (NASDAQ:RGNX) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Patrick Christmas - Senior Vice President and General Counsel Kenneth Mills - President and Chief Executive Officer Stephen Pakola - Chief Medical Officer Vittal Vasista - Chief Financial Officer Conference Call Participants Gena Wang - Barclays Gbola Amusa - Chardan Capital Markets Mani Foroohar - SVB Leerink Costas Liappas - Morgan Stanley Operator Good afternoon, and welcome to the REGENXBIO First Q ...

REGENXBIO, Inc. (NASDAQ:RGNX) Q4 2019 Earnings Conference Call February 26, 2020 4:30 PM ET Company Participants Patrick Christmas - Senior Vice President and General Counsel Kenneth Mills - President and Chief Executive Officer Stephen Pakola - Chief Medical Officer Vittal Vasista - Chief Financial Officer Conference Call Participants Gena Wang - Barclays Connor Meehan - Morgan Stanley Gbola Amusa - Chardan Capital Markets Mani Foroohar - SVB Leerink Operator Good afternoon, and welcome to the REGENXBIO Fo ...

REGENXBIO, Inc. (NASDAQ:RGNX) Q3 2019 Earnings Conference Call November 5, 2019 4:30 PM ET Company Participants Patrick Christmas - Senior Vice President and General Counsel Kenneth Mills - President and Chief Executive Officer Stephen Pakola - Chief Medical Officer Vittal Vasista - Chief Financial Officer Conference Call Participants Gena Wang - Barclays PLC Mani Foroohar - SVB Leerink Kostas Biliouris - Morgan Stanley Operator Good afternoon, and welcome to the REGENXBIO Third Quarter 2019 Earnings Confer ...

Corporate Presentation Leader in AAV Gene Therapy September 6, 2019 Forward-looking statements This presentation includes "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements express a belief, expectation or intention and are generally accompanied by words that convey projected future events or outcomes such as "believe," "may," "will," "estimate," "continue," "anticipat ...

Regenxbio, Inc. (NASDAQ:RGNX) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Sara Garon Berl - Vice President of Law and Policy for REGENXBIO Kenneth Mills – Chief Executive Offier, President and Director Vittal Vasista - Chief Financial Officer Steve Pakola - Chief Medical Officer Conference Call Participants Mani Foroohar - SVB Leerink Gena Wang - Barclays Operator Good afternoon and welcome to the REGENXBIO Second Quarter 2019 Earnings Conference Call. At this time, all p ...

Regenxbio, Inc. (NASDAQ:RGNX) Q1 2019 Earnings Conference Call May 7, 2019 4:30 PM ET Company Participants Patrick Christmas - SVP & General Counsel Kenneth Mills - CEO, President & Director Steve Pakola - Chief Medical Officer Vittal Vasista - CFO Conference Call Participants Matthew Harrison - Morgan Stanley Gena Wang - Barclays Bank Mani Foroohar - SVB Leerink Joshua Schimmer - Evercore ISI Operator Good afternoon and welcome to the REGENXBIO First Quarter 2019 Earnings Conference Call. At this time, all ...

REGENXBIO (NASDAQ:RGNX) Q4 2018 Results Earnings Conference Call February 27, 2019 4:30 AM ET Company Participants Patrick Christmas - Senior Vice President, General Counsel Ken Mills - President, Chief Executive Officer Vit Vasista - Senior Vice President, Chief Financial Officer Conference Call Participants Xiaobin Gao - Barclays Gbola Amusa - Chardan Reni Benjamin - Raymond James Mani Foroohar - Leerink Operator Good afternoon and welcome to the REGENXBIO fourth quarter and full year 2018 earnings confer ...